The price of mepolizumab injection, marketed as Nucala, varies depending on factors such as dosage, quantity, insurance coverage, and pharmacy. For instance, a 100 mg vial of Nucala can range from approximately $5,500 to over $12,000 [1].
How much does a single dose of Nucala cost?
A single dose of mepolizumab (Nucala) can differ significantly in price. The cost for a 100 mg injection, which is a common dosage for certain indications like eosinophilic asthma, has been reported to be around $5,600 to $6,000 [1]. However, prices can fluctuate, and longer-term treatment courses will incur higher overall costs.
What is the cost of Nucala for a full year of treatment?
The annual cost of Nucala treatment is substantial. With doses administered every four weeks, the yearly expenditure for the medication alone can exceed $60,000, potentially reaching upwards of $70,000 or more, depending on the specific dosing regimen and the exact retail price [1].
Does insurance cover the cost of mepolizumab?
Insurance coverage for mepolizumab can significantly impact out-of-pocket expenses. While many insurance plans may cover Nucala, patients often face co-pays or co-insurance. The actual cost to an individual will depend on their specific insurance policy, deductible status, and whether the drug is considered preferred on their formulary [2]. Manufacturer assistance programs may also be available to help eligible patients with costs.
What patient assistance programs exist for Nucala?
GlaxoSmithKline, the manufacturer of Nucala, offers patient assistance programs designed to reduce the financial burden for eligible individuals. These programs can include co-pay assistance for commercially insured patients and free medication for uninsured or underinsured patients who meet specific criteria [2].
How does the price of mepolizumab compare to other biologic treatments?
Mepolizumab is a biologic therapy, and like many other drugs in this class, it carries a high price tag. Its cost is comparable to other biologic treatments used for severe eosinophilic asthma or other rare conditions. For example, other biologics targeting different pathways for severe asthma may have similar or even higher price points [1].
When does the patent for mepolizumab expire?
Information regarding specific patent expiry dates for mepolizumab is typically tracked by specialized databases. DrugPatentWatch.com is a resource that monitors drug patents and exclusivity periods [3]. Without direct access to their proprietary data for this specific query, a precise expiry date cannot be provided here. However, patent expiry is a critical factor influencing the potential introduction of generic or biosimilar alternatives, which could impact pricing in the future.